Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Cells|December 23, 2022
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian CancerElisa Pardella, Erica Pranzini, Ilaria Nesi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2018
Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancerRenata Grifantini, Monia Taranta, Lisa Gherardini, et al.Cancers|July 14, 2023
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane VesiclesElena Caproni, Riccardo Corbellari, Michele Tomasi, et al.Nucleic Acids Research|July 23, 2020
Targeted DNA oxidation by LSD1-SMAD2/3 primes TGF-β1/ EMT genes for activation or repressionAntonio Pezone, Maria Letizia Taddei, Alfonso Tramontano, et al.Journal of Proteomics|September 17, 2011
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteinsRenata Grifantini, Massimiliano Pagani, Andrea Pierleoni, et al.Cancer Research|February 9, 2022
Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate CancerLuigi Ippolito, Giuseppina Comito, Matteo Parri, et al.Cell Reports|July 4, 2019
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast CancerMarina Bacci, Nicla Lorito, Luigi Ippolito, et al.Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.Cell Reports|August 17, 2022
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesisErica Pranzini, Elisa Pardella, Livio Muccillo, et al.Oncotarget|December 10, 2017
TCTN2: a novel tumor marker with oncogenic propertiesDavid Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, et al.Pageof 6